Tag Archives: ICPT

No Comments

Blogging Options: CBOE Morning Update 8.12.14

Stock futures off a little as Ukraine and Iraq situations prompt some profit takers to lock in gains from the last two sessions.  Small business optimism up slightly. Volatility as an asset class: Intercept Pharmaceuticals (ICPT) is up $119.43 to $356.60 in the premarket after announcing an experimental liver disease drug may have had a […]